Scintigraphy with 99 mTc ( V )-DMSA in monitoring patients with inflammatory bowel disease

The clinical significance of pentavalent technetium-99m dimercaptosuccinic acid (99mTc(V)DMSA) scintigraphy in diagnosing inflammatory bowel disease (IBD) has not yet been fully elucidated. The aim of this prospective paper was to study the above. This study included 54 patients, 22 females and 32 males (mean age: 36.68±11.49; range: 18-63 years) with IBD who came to our clinics for follow-up and were examined clinically by colonoscopy and 99mTc(V)-DMSA scintigraphy. On the follow-up studies, five patients (9.25%) relapsed, and 49 (90.74%) remained at a steady condition. There was a good correlation between the scintigraphic results and the clinical and colonoscopy data of the patients (P<0.05). In conclusion, our results indicated that 99mTc(V)DMSA scintigraphy can be complementary to colonoscopy for the diagnostic evaluation of IBD.

[1]  I. Nabipour,et al.  Diagnostic value of 99mTc-ubiquicidin scintigraphy for osteomyelitis and comparisons with 99mTc-methylene diphosphonate scintigraphy and magnetic resonance imaging , 2011, Nuclear medicine communications.

[2]  I. Nabipour,et al.  Diagnostic value of 99mTc-ubiquicidin scintigraphy for osteomyelitis and comparisons with 99mTc-methylene diphosphonate scintigraphy and magnetic resonance imaging , 2011, Nuclear medicine communications.

[3]  M. Assadi,et al.  The Diagnostic Value of 99 mTc-IgG Scintigraphy in the Diabetic Foot and Comparison with 99 mTc-MDP Scintigraphy , 2011 .

[4]  S. Koukouraki,et al.  Role of scintigraphy in inflammatory bowel disease. , 2009, World journal of gastroenterology.

[5]  D. Halpenny,et al.  Role of PET and combination PET/CT in the evaluation of patients with inflammatory bowel disease , 2009, Inflammatory bowel diseases.

[6]  V. Volf,et al.  99mTc-HMPAO-Labelled Leukocytes Scintigraphy in Monitoring Children and Adolescents with IBD , 2009 .

[7]  E. Kouroumalis,et al.  Is there a role for Tc-99m (V) DMSA scintigraphy in ischemic colitis? , 2008, World journal of gastroenterology.

[8]  A. Yıldız,et al.  Technetium-99m hexamethyl propylene amine oxime-labeled leukocyte scintigraphy at three different times in active ulcerative colitis: comparison with colonoscopy and clinico-biochemical parameters in the assessment of disease extension and severity , 2008, Annals of nuclear medicine.

[9]  Roelof J Bennink,et al.  Magnetic resonance imaging in Crohn's disease , 2008 .

[10]  J. Moschandreas,et al.  Active inflammatory bowel disease: head-to-head comparison between 99mTc-hexamethylpropylene amine oxime white blood cells and 99mTc(V)-dimercaptosuccinic acid scintigraphy , 2008, Nuclear medicine communications.

[11]  Jaap Stoker,et al.  Inflammatory Bowel Disease Diagnosed with US, MR, Scintigraphy, and CT: Meta- , 2008 .

[12]  A. Carriero,et al.  Inflammatory chronic disease of the colon: how to image. , 2007, European journal of radiology.

[13]  S. Koukouraki,et al.  Diagnostic efficacy of technetium-99m pentavalent-dimercapto succinic acid versus gallium-67 citrate, imaging in patients with highly suspected acute bone and joint infections. , 2006, Hellenic journal of nuclear medicine.

[14]  G. Porro,et al.  Imaging inflammatory bowel disease using bowel ultrasound , 2005, European journal of gastroenterology & hepatology.

[15]  E. Chilvers,et al.  Quantification of disease activity in patients undergoing leucocyte scintigraphy for suspected inflammatory bowel disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  L. Mortelmans,et al.  Evaluation of early treatment response and predicting the need for colectomy in active ulcerative colitis with 99mTc-HMPAO white blood cell scintigraphy. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  D. Hommes,et al.  Endoscopy in inflammatory bowel diseases. , 2004, Gastroenterology.

[18]  I. Fogelman,et al.  Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease , 1993, European Journal of Nuclear Medicine.

[19]  P. Beck,et al.  A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management , 2003, American Journal of Gastroenterology.

[20]  E. Kouroumalis,et al.  Active inflammatory bowel disease: evaluation with 99mTc (V) DMSA scintigraphy. , 2003, Radiology.

[21]  M. Neurath,et al.  Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies , 2002, American Journal of Gastroenterology.

[22]  K. Tsai,et al.  Use of 99mTc (V) DMSA scintigraphy in the detection and localization of intestinal inflammation: comparison of findings and colonoscopy and biopsy. , 2001, Radiology.

[23]  S. Fisher,et al.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.

[24]  S. Hanauer,et al.  Management of Crohn's disease in adults , 2001, American Journal of Gastroenterology.

[25]  K. Karlinger,et al.  The role of nuclear medicine in inflammatory bowel disease. A review with experiences of aspecific bowel activity using immunoscintigraphy with 99mTc anti-granulocyte antibodies. , 2000, European journal of radiology.

[26]  E. Prats,et al.  Clinical applications of radiolabeled blood elements in inflammatory bowel disease. , 1999, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[27]  G. C. Liu,et al.  Technetium-99m(V)-DMSA and gallium-67 in the assessment of bone and joint infection. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  L. Chauvelot‐Moachon,et al.  Technetium Tc 99m hexamethyl propylene amine oxine leukocyte scintigraphy in patients with ulcerative colitis: correlation with clinical, biologic, endoscopic, and pathologic intensity, and local release of interleukin 8. , 1998, Gastrointestinal endoscopy.

[29]  N. Shuke,et al.  Tc-99m leukocyte imaging for evaluating disease severity and monitoring treatment response in ulcerative colitis: comparison with colonoscopy. , 1998, Clinical nuclear medicine.

[30]  P. Chapman,et al.  Visualising E-selectin in the detection and evaluation of inflammatory bowel disease , 1998, Gut.

[31]  C. C. Yang,et al.  Psoas muscle abscess causing fever of unknown origin: the value of Tc-99m (V) DMS imaging. , 1997, Clinical nuclear medicine.

[32]  W. Gianni,et al.  Preliminary evaluation of the usefulness of Tc-99m (V) DMSA in pancreatic neuroendocrine tumors. , 1996, Clinical nuclear medicine.

[33]  Hisataka Kobayashi,et al.  Diagnostic Value of Tc‐99m (V) DMSA for Chondrogenic Tumors With Positive Tc‐99m HMDP Uptake on Bone Scintigraphy , 1995, Clinical nuclear medicine.

[34]  B. Shepstone,et al.  Pentavalent Tc-99m DMSA Scintigraphy: Prospective Evaluation of Its Role in the Management of Patients with Medullary Carcinoma of the Thyroid , 1991, Clinical nuclear medicine.

[35]  H. Schmidt,et al.  Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label. , 1988, Gastroenterology.